Skip to main content
Clinical Trials/JPRN-jRCT1030200197
JPRN-jRCT1030200197
Recruiting
Phase 3

Effects of a Mindfulness-Based Eating Awareness Training online intervention in adults of obesity:A randomized controlled trials - Online Mindfulness-Based Eating Awareness Training for obesity.

Ono Hiraku0 sites32 target enrollmentNovember 12, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ono Hiraku
Enrollment
32
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 12, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ono Hiraku

Eligibility Criteria

Inclusion Criteria

  • 1\)Primary diagnosis of Obesity with a BMI of 30 or higher
  • 2\)The age between 18 to 65\.
  • 3\)Patients with full consent of participation in the study.
  • 4\)Possible to communicate in Japanese.
  • 5\)Patients who have an internet environment at home and have a personal computer or tablet device.
  • 6\)No addition of weight loss drug or appetite suppressant during the study
  • 7\)Possible to understand Mindfulness\-Based Eating Awareness Training and have mental and physical
  • condition that can be participate the session for at least 6 months.
  • 8\)If Obesity is primary diagnosed, patients with Depressive Disorder and Anxiety Disorder will not be
  • excluded from the study.

Exclusion Criteria

  • 1\)Pregnant, lactating or less than 6 months after giving birth.
  • 2\)Patients who taking weight loss drugs or appetite suppressants.
  • 3\)Patients who plan undergo Bariatric surgery.
  • 4\)Patients who have Org anic brain disorder (including Dementia), Psychosis, Substance abuse or dependence, other severe mental disorders.
  • 5\)Active suicidality
  • 6\)Repetitive anti\-social behavior
  • 7\)Severe physical condition
  • 8\)IQ under 80 by evaluating the JART25 (Japanese Adult Reading Test25\) or IQ under 70 by Wechsler Adult Intelligence Scale.
  • 9\)Patients with Autism Spectrum Disorder.
  • 10\)Patients who cannot contact with the study organizer.

Outcomes

Primary Outcomes

Not specified

Similar Trials